MUSC childrens hospital first in nation to administer potential treatment for MIS-C – Live 5 News WCSC

The treatment was actually developed for another purpose: to try to treat stem cell transplant patients who develop graft-versus-host disease, GVHD, that doesnt respond to steroid treatments, hospital officials said. " GVHD occurs when transplanted stem cells mount an immune system attack against the recipients body. The hope is that the treatment will work against MIS-C, too, because its also a harmful immune system reaction to a perceived enemy.

Continued here:

MUSC childrens hospital first in nation to administer potential treatment for MIS-C - Live 5 News WCSC